> Rumor Mill:Â Generic drugmaker Dr. Reddy's Laboratories is said to have submitted a bid for U.S.-based Bradley Pharma. FiercePharma
> Novartis has licensed MedImmune's reverse genetics intellectual property. Novartis will use the IP to support development of vaccine strains for seasonal, pre-pandemic and pandemic influenza vaccines. Financial details of the deal were not disclosed. Release
> Precision Therapeutics, which makes tests to analyze tumor cells, is planning an $80.5 million IPO. Report
> Two Massachusetts General Hospital researchers describe a way of creating novel enzymes that, for the first time, do not require prior understanding of exactly how the enzymes work. FierceBioresearcher
> A group of neurologists have been studying the role a particular enzyme plays in creating memories, saying that blocking the enzyme could offer a new approach to treating post-traumatic stress disorders as well as chronic pain. FierceBioresearcher
And Finally... The FDA wants more detailed sunscreen labels. Report